Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Revenue
Charles River Laboratories International Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Revenue
$4.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Charles River Laboratories International Inc
Revenue Breakdown
Breakdown by Geography
Charles River Laboratories International Inc
Total Revenue:
4.1B
USD
|
United States:
2.3B
USD
|
Europe:
1.1B
USD
|
Canada:
487.3m
USD
|
Asia Pacific:
200.8m
USD
|
Other:
16.8m
USD
|
Breakdown by Segments
Charles River Laboratories International Inc
Total Revenue:
4.1B
USD
|
Cost Of Services Provided (Excluding Amortiza...:
3.4B
USD
|
Dsa:
2.6B
USD
|
Rms:
792.3m
USD
|
Manufacturing:
721.4m
USD
|
Cost Of Products Sold (Excluding Amortization...:
689.4m
USD
|
See Also
What is Charles River Laboratories International Inc's Revenue?
Revenue
4.1B
USD
Based on the financial report for Dec 30, 2023, Charles River Laboratories International Inc's Revenue amounts to 4.1B USD.
What is Charles River Laboratories International Inc's Revenue growth rate?
Revenue CAGR 10Y
13%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Charles River Laboratories International Inc have been 12% over the past three years , 13% over the past five years , and 13% over the past ten years .